文献速递胸部肿瘤

ASXL1克隆性造血与肺癌风险的基因特异性分析

Gene-Specific Analysis of Clonal Hematopoiesis Identifies the Association Between ASXL1 and Lung Cancer Risk.
PubMed 文献 · J Thorac Oncol · 2026-09-28

该研究基于英国生物银行与All of Us两个大型人群队列,对19种常见实体瘤进行基因特异性CHIP分析。结果显示CHIP与实体瘤的关联具有癌种特异性,肺癌关联最强且主要由ASXL1突变克隆驱动,高变异等位基因频率ASXL1与风险升高相关(HR=3.2),该关联仅限于吸烟者,并在MSK-IMPACT与TCGA队列中得到验证。

要点

  • CHIP与实体瘤的关联具有癌种特异性,肺癌关联最强。
  • 高VAF的ASXL1克隆与肺癌风险升高相关(HR=3.2)。
  • ASXL1 CHIP与肺癌风险的关联仅见于曾经吸烟者。

核心结论

  • CHIP与实体瘤的关联高度依赖癌种,肺癌关联最强且由ASXL1突变克隆驱动。
  • 吸烟相关的ASXL1突变克隆扩增与肺癌风险升高相关,基因特异性CHIP指标或可改善风险分层与早期筛查。

研究设计与样本

  • 基于英国生物银行与All of Us两个大型人群队列,对19种常见实体瘤进行基因特异性CHIP分析。
  • 采用Cox比例风险模型与嵌套病例对照logistic模型。
  • 在MSK-IMPACT与TCGA两个独立肿瘤队列中验证ASXL1 CHIP在肺癌中的富集。

主要发现

  • CHIP与实体瘤的关联具有癌种特异性,肺癌关联最强。
  • 肺癌关联主要由ASXL1突变克隆驱动,高变异等位基因频率ASXL1与风险升高相关(HR=3.2)。
  • 校正年龄、性别、体重指数、吸烟状态与遗传 ancestry 后关联依然稳健。
  • ASXL1 CHIP在吸烟者中显著富集,其与肺癌风险的关联仅限于曾经吸烟者。

关键数值与推荐

  • 高VAF的ASXL1克隆与肺癌风险升高相关,风险比(HR)=3.2。
  • ASXL1 CHIP与肺癌风险的关联仅在曾经吸烟者中观察到。

临床怎么用

  • 对吸烟者检测基因特异性CHIP(尤其ASXL1)或有助于肺癌风险分层与早期筛查。
  • CHIP风险评估应关注癌种特异性及基因与环境的交互,而非泛化的CHIP状态。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Clonal hematopoiesis of indeterminate potential (CHIP) is a recognized risk factor for hematologic malignancies, but its contribution to different types of solid cancers remains incompletely defined. METHODS: Here, we performed a systematic, gene-specific analysis of CHIP across 19 common solid cancer types using two large population-based cohorts, the United Kingdom Biobank and All of Us, with Cox proportional hazards models and nested case-control logistic models. RESULTS: We report that the relationship between CHIP and solid tumors is highly cancer-type specific, with lung cancer exhibiting the strongest association. In lung cancer, this association is largely driven by ASXL1-mutant clones. Specifically, high variant allele fraction ASXL1 was associated with an increased risk (hazard ratio = 3.2), and the association remained robust after adjustment for age, sex, body mass index, smoking status, and genetic ancestry. Notably, ASXL1 CHIP was substantially enriched among smokers, and its association with lung cancer risk was restricted to ever-smokers, highlighting a key interaction between CHIP and environmental exposure. The enrichment of ASXL1 CHIP in lung cancer was further validated in two independent cancer-only cohorts, including Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) and The Cancer Genome Atlas (TCGA). CONCLUSIONS: Collectively, our findings support a model in which smoking-associated expansion of ASXL1-mutant clones is associated with an increased risk of lung cancer and suggest that gene-specific CHIP metrics may enhance risk stratification and early detection strategies.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Zhang Z, Dong J, Huang Y, et al. Gene-Specific Analysis of Clonal Hematopoiesis Identifies the Association Between ASXL1 and Lung Cancer Risk. J Thorac Oncol. 2026. PMID: 42805460. doi:10.1016/j.jtho.2026.106124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。